[HTML][HTML] Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation

RL Schmidt, LL Lenz - 2012 - journals.plos.org
RL Schmidt, LL Lenz
2012journals.plos.org
Inflammasome activation permits processing of interleukins (IL)-1β and 18 and elicits cell
death (pyroptosis). Whether these responses are independently licensed or are “hard-wired”
consequences of caspase-1 (casp1) activity has not been clear. Here, we show that that
each of these responses is independently regulated following activation of NLRP3
inflammasomes by a “non-canonical” stimulus, the secreted Listeria monocytogenes (Lm)
p60 protein. Primed murine dendritic cells (DCs) responded to p60 stimulation with reactive …
Inflammasome activation permits processing of interleukins (IL)-1β and 18 and elicits cell death (pyroptosis). Whether these responses are independently licensed or are “hard-wired” consequences of caspase-1 (casp1) activity has not been clear. Here, we show that that each of these responses is independently regulated following activation of NLRP3 inflammasomes by a “non-canonical” stimulus, the secreted Listeria monocytogenes (Lm) p60 protein. Primed murine dendritic cells (DCs) responded to p60 stimulation with reactive oxygen species (ROS) production and secretion of IL-1β and IL-18 but not pyroptosis. Inhibitors of ROS production inhibited secretion of IL-1β, but did not impair IL-18 secretion. Furthermore, DCs from caspase-11 (casp11)-deficient 129S6 mice failed to secrete IL-1β in response to p60 but were fully responsive for IL-18 secretion. These findings reveal that there are distinct licensing requirements for processing of IL-18 versus IL-1β by NLRP3 inflammasomes.
PLOS